FARE Capital – Launch and first investment of FARE Capital Impact Fund

Today, Mike de Leeuw, CEO of My Life Technologies, sounded the gong to celebrate the first investment of the FARE Capital Impact Fund. The fund of FARE Capital has invested in My Life Technologies, which produces and develops a special technique where drugs are delivered through the skin. The group was welcomed by Lennart Visser, Junior Product Manager and Robin van Rijn, Client Relationship Manager of Euronext Amsterdam.